Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Anticoagulant therapy in acute lung injury: a useful tool without proper operating instruction?

    Rehberg S, Enkhbaatar P, Traber DL.

    Crit Care. 2008;12(5):179. Epub 2008 Sep 22.PMID: 18828885 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis.

    Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, Cox RA, Huda R, Hawkins HK, Morita N, Murakami K, Mizutani A, Herndon DN, Traber DL.

    Crit Care Med. 2006 Sep;34(9):2432-8.PMID: 16810106 [PubMed - indexed for MEDLINE]Related articles

    3.

    Anticoagulant therapy in acute lung injury.

    Laterre PF, Wittebole X, Dhainaut JF.

    Crit Care Med. 2003 Apr;31(4 Suppl):S329-36. Review.PMID: 12682461 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

    Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourrier F, Guery BP.

    Respir Res. 2006 Mar 22;7:41.PMID: 16553944 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Randomized clinical trial of activated protein C for the treatment of acute lung injury.

    Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA.

    Am J Respir Crit Care Med. 2008 Sep 15;178(6):618-23. Epub 2008 Jun 19.PMID: 18565951 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep.

    Waerhaug K, Kuklin VN, Kirov MY, Sovershaev MA, Langbakk B, Ingebretsen OC, Ytrehus K, Bjertnaes LJ.

    Crit Care. 2008;12(4):R104. Epub 2008 Aug 15.PMID: 18702832 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Nebulised heparin: a new approach to the treatment of acute lung injury?

    Suter PM.

    Crit Care. 2008;12(4):170. Epub 2008 Jul 25.PMID: 18671836 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis.

    Bernard GR, Ely EW, Wright TJ, Fraiz J, Stasek JE Jr, Russell JA, Mayers I, Rosenfeld BA, Morris PE, Yan SB, Helterbrand JD.

    Crit Care Med. 2001 Nov;29(11):2051-9.PMID: 11700394 [PubMed - indexed for MEDLINE]Related articles

    9.

    Recombinant human activated protein C for severe sepsis in neonates.

    Kylat RI, Ohlsson A.

    Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005385. Review.PMID: 16625638 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Role of coagulation in acute pulmonary lesion physiopathology. Parallelism with sepsis]

    Ferrer R, Navas A, Adda M, Artigas A.

    Med Intensiva. 2008 Aug-Sep;32(6):304-11. Spanish. PMID: 18601838 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.

    de Pont AC, Bakhtiari K, Hutten BA, de Jonge E, Vroom MB, Meijers JC, Büller HR, Levi M.

    Crit Care. 2005 Oct 5;9(5):R490-7. Epub 2005 Jul 21.PMID: 16277710 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Evolution of treatments for patients with acute lung injury.

    Esper AM, Martin GS.

    Expert Opin Investig Drugs. 2005 May;14(5):633-45. Review.PMID: 15926869 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pulmonary coagulopathy as a new target in lung injury--a review of available pre-clinical models.

    Hofstra JJ, Juffermans NP, Schultz MJ, Zweers MM.

    Curr Med Chem. 2008;15(6):588-95. Review.PMID: 18336273 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inhaled activated protein C: a novel therapy for acute lung injury?

    Liu KD, Looney MR, Matthay MA.

    Crit Care. 2009;13(3):150. Epub 2009 May 21.PMID: 19519935 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis.

    Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E.

    Blood. 2004 Dec 15;104(13):3878-85. Epub 2004 Aug 31. Erratum in: Blood. 2005 May 15;105(10):3785. PMID: 15339848 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.

    Derhaschnig U, Reiter R, Knöbl P, Baumgartner M, Keen P, Jilma B.

    Blood. 2003 Sep 15;102(6):2093-8. Epub 2003 May 15.PMID: 12750166 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.

    He HY, Wang C, Pang BS.

    Chin Med J (Engl). 2008 Dec 20;121(24):2561-5.PMID: 19187596 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure.

    Brueckmann M, Wizenmann J, Hoffmann U, Seeger M, Bewig B.

    Thromb Res. 2003 Mar 15;109(5-6):259-63.PMID: 12818248 [PubMed - indexed for MEDLINE]Related articles

    20.

    Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.

    Idell S.

    Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. Review.PMID: 12682443 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data